Facebook Twitter LinkedIn Google Plus RSS

Cancer Genetics appoints new CFO

By ,

Rutherford-based Cancer Genetics, an emerging DNA-based diagnostics, announced Monday it has appointed Edward J. Sitar, CPA as chief financial officer effective April 1, 2014.

According to the announcement, Sitar will be responsible for all corporate finance and accounting activities for the company.

He was most recently CFO of Healthagen, a subsidiary of Aetna.  Prior to that, he was the executive vice president and CFO of ActiveHealth Management, also a subsidiary of Aetna.

The company also announced the resignation of Elizabeth Adkins Czerepak, CFO and principal accounting officer, effective March 31, 2014, the announcement said.


Real Estate Report: Bill O'Dea, with just a pad and pen, can tell if projects make sense

Beach Haus brewery set to transform iconic bakery site in Belmar

Most-read March 17: Next hot spots (three towns ready to grow)

More From This Industry

Emily Bader

Emily Bader

Emily Bader is the Web Editor and Social Media Coordinator at NJBIZ. She is a Brielle, N.J. native and a Rutgers University alum. You can contact her at emilyb@njbiz.com.

Leave a Comment


Please note: All comments will be reviewed and may take up to 24 hours to appear on the site.

Post Comment
View Comment Policy